Co-Authors
This is a "connection" page, showing publications co-authored by NAOTO T UENO and BEDRICH ECKHARDT.
Connection Strength
1.913
-
A target of potential RELAvance in inflammatory breast cancer. Oncotarget. 2017 04 18; 8(16):25835-25836.
Score: 0.615
-
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research. PLoS One. 2020; 15(4):e0231953.
Score: 0.190
-
Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis. Cancer Res. 2020 03 15; 80(6):1304-1315.
Score: 0.186
-
Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux. Oncogene. 2019 03; 38(12):2135-2150.
Score: 0.172
-
Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies. PLoS One. 2018; 13(5):e0195932.
Score: 0.166
-
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer. Oncotarget. 2017 Sep 15; 8(40):67904-67917.
Score: 0.156
-
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression. Breast Cancer Res Treat. 2017 Jul; 164(1):57-67.
Score: 0.154
-
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype? Oncotarget. 2015 May 30; 6(15):12890-908.
Score: 0.135
-
NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. J Natl Cancer Inst. 2022 04 11; 114(4):579-591.
Score: 0.054
-
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer. J Pathol. 2020 05; 251(1):63-73.
Score: 0.047
-
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. Proc Natl Acad Sci U S A. 2016 Nov 08; 113(45):12780-12785.
Score: 0.037